Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Policy / Pricing

FDA Releases Congressional Justification for FY 2027 Budget, Including Proposal Regarding Interchangeability of Biosimilars

 April 22, 2026

Big Molecule Watch

The U.S.

Policy / PricingRead full story

Post navigation

Medicare weight loss drug pilot on ice as insurers decline to contribute →

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com